Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity-When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood
- PMID: 36293446
- PMCID: PMC9603863
- DOI: 10.3390/ijms232012592
Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity-When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood
Abstract
The mineralocorticoid receptor (MR) is a member of the steroid receptor family and acts as a ligand-dependent transcription factor. In addition to its classical effects on water and electrolyte balance, its involvement in the pathogenesis of cardiovascular and renal diseases has been the subject of research for several years. The molecular basis of the latter has not been fully elucidated, but an isolated increase in the concentration of the MR ligand aldosterone or MR expression does not suffice to explain long-term pathologic actions of the receptor. Several studies suggest that MR activity and signal transduction are modulated by the surrounding microenvironment, which therefore plays an important role in MR pathophysiological effects. Local changes in micromilieu, including hypoxia, ischemia/reperfusion, inflammation, radical stress, and aberrant salt or glucose concentrations affect MR activation and therefore may influence the probability of unphysiological MR actions. The surrounding micromilieu may modulate genomic MR activity either by causing changes in MR expression or MR activity; for example, by inducing posttranslational modifications of the MR or novel interaction with coregulators, DNA-binding sites, or non-classical pathways. This should be considered when developing treatment options and strategies for prevention of MR-associated diseases.
Keywords: aldosterone; cardiovascular aging; hyperglycemia; hypoxia; inflammation; micromilieu; mineralocorticoid receptor.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9603863/bin/ijms-23-12592-g001.gif)
Similar articles
-
Structure-function relationships of the aldosterone receptor.Vitam Horm. 2023;123:285-312. doi: 10.1016/bs.vh.2022.12.007. Epub 2023 Jan 10. Vitam Horm. 2023. PMID: 37717989 Review.
-
Mineralocorticoid receptor actions in cardiovascular development and disease.Essays Biochem. 2021 Dec 17;65(6):901-911. doi: 10.1042/EBC20210006. Essays Biochem. 2021. PMID: 34414409 Review.
-
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Nongenomic effects via the mineralocorticoid receptor.J Endocrinol. 2017 Jul;234(1):T107-T124. doi: 10.1530/JOE-16-0659. Epub 2017 Mar 27. J Endocrinol. 2017. PMID: 28348113 Review.
-
Rapid mineralocorticoid receptor trafficking.Steroids. 2014 Mar;81:103-8. doi: 10.1016/j.steroids.2013.10.016. Epub 2013 Nov 16. Steroids. 2014. PMID: 24252381
-
New aspects of rapid aldosterone signaling.Mol Cell Endocrinol. 2009 Sep 24;308(1-2):53-62. doi: 10.1016/j.mce.2009.02.005. Epub 2009 Feb 28. Mol Cell Endocrinol. 2009. PMID: 19549592 Review.
References
-
- Nahum L.H. The renin angiotensin-aldosterone system (RAAS) in normal man. Conn. Med. 1965;29:710–711. - PubMed
-
- Pearce D., Bhargava A., Cole T.J. Aldosterone: Its receptor, target genes, and actions. Vitam. Horm. 2003;66:29–76. - PubMed
-
- Kanatsou S., Joels M., Krugers H. Brain Mineralocorticoid Receptors and Resilience to Stress. Vitam. Horm. 2019;109:341–359. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources